Properties and Opioid Inhibition of Mesolimbic Dopamine Neurons Vary According to Target Location

Overview

Journal J Neurosci

Specialty Neurology

Date 2006 Mar 10

PMID 16525058

Citations 206

Authors

Christopher P Ford

Gregory P Mark

John T Williams

Affiliations

Soon will be listed here.

Abstract

The mesolimbic dopamine system, which mediates the rewarding properties of nearly all drugs of abuse, originates in the ventral tegmental area (VTA) and sends major projections to both the nucleus accumbens (NAc) and the basolateral amygdala (BLA). To address whether differences occur between neurons that project to these separate areas, retrograde microspheres were injected to either the BLA or the NAc of DBA/2J mice. Whole-cell recordings were made from labeled VTA dopamine neurons. We found that identified neurons that projected to the BLA and NAc originated within different quadrants of the VTA with neither group exhibiting large-amplitude h-currents. Neurons that projected to the NAc exhibited a greater outward current in response to the kappa-opioid agonist (5alpha,7alpha,8alpha)-(+)-N-methyl-N-[7-(pyrrolidinyl)-1-oxaspiro [4,5]dec-8-yl]-benzeneacetamide (U69593; 200 nM), whereas neurons that projected to the BLA exhibited greater inhibition to the mu/delta opioid agonist [Met5] enkephalin (ME; 3 microM). In addition, we found that the presynaptic inhibition of GABAergic transmission at both GABAA and GABAB receptors was differentially regulated by U69593 between the two groups. When dopamine IPSCs were examined, U69593 caused a greater inhibition in NAc- than BLA-projecting neurons. ME had no effect on either. Finally, the regulation of extracellular dopamine by dopamine uptake transporters was equal across the VTA. These results suggest that opioids differentially inhibit mesolimbic neurons depending on their target projections. Identifying the properties of projecting mesolimbic VTA dopamine neurons is crucial to understanding the action of drugs of abuse.

Citing Articles

Untangling dopamine and glutamate in the ventral tegmental area.

Prevost E, Ward L, Alas D, Aimale G, Ikenberry S, Fox K bioRxiv. 2025; .

PMID: 40060543 PMC: 11888473. DOI: 10.1101/2025.02.25.640201.

Cross-species dissection of the modular role of the ventral tegmental area in depressive disorders.

Morris L, Beltran J, Beltran J, Murrough J, Morel C Neuroscience. 2025; 569:248-266.

PMID: 39914519 PMC: 11885014. DOI: 10.1016/j.neuroscience.2025.02.008.

Transient nicotine exposure in early adolescent male mice freezes their dopamine circuits in an immature state.

Reynolds L, Gulmez A, Fayad S, Campos R, Rigoni D, Nguyen C Nat Commun. 2024; 15(1):9017.

PMID: 39424848 PMC: 11489768. DOI: 10.1038/s41467-024-53327-w.

State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons.

Basso V, Dobrossy M, Thompson L, Kirik D, Fuller H, Gates M Biology (Basel). 2024; 13(9).

PMID: 39336117 PMC: 11428604. DOI: 10.3390/biology13090690.

Distinct Neuromodulatory Effects of Endogenous Orexin and Dynorphin Corelease on Projection-Defined Ventral Tegmental Dopamine Neurons.

Mohammadkhani A, Qiao M, Borgland S J Neurosci. 2024; 44(39).

PMID: 39187377 PMC: 11426376. DOI: 10.1523/JNEUROSCI.0682-24.2024.

References

Ikemoto S, Panksepp J . The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev. 1999; 31(1):6-41. DOI: 10.1016/s0165-0173(99)00023-5. View

Liss B, Haeckel O, Wildmann J, Miki T, Seino S, Roeper J . K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat Neurosci. 2005; 8(12):1742-51. DOI: 10.1038/nn1570. View

Joel D, Weiner I . The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience. 2000; 96(3):451-74. DOI: 10.1016/s0306-4522(99)00575-8. View

Williams J, Christie M, Manzoni O . Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev. 2001; 81(1):299-343. DOI: 10.1152/physrev.2001.81.1.299. View

Cragg S, Nicholson C, Tao L, Rice M . Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake. J Neurophysiol. 2001; 85(4):1761-71. DOI: 10.1152/jn.2001.85.4.1761. View

See R, Kruzich P, Grimm J . Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacology (Berl). 2001; 154(3):301-10. DOI: 10.1007/s002130000636. View

Garzon M, Pickel V . Plasmalemmal mu-opioid receptor distribution mainly in nondopaminergic neurons in the rat ventral tegmental area. Synapse. 2001; 41(4):311-28. DOI: 10.1002/syn.1088. View

Everitt B, Dickinson A, Robbins T . The neuropsychological basis of addictive behaviour. Brain Res Brain Res Rev. 2001; 36(2-3):129-38. DOI: 10.1016/s0165-0173(01)00088-1. View

Neuhoff H, Neu A, Liss B, Roeper J . I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J Neurosci. 2002; 22(4):1290-302. PMC: 6757558. View

10.

Dodt H, Eder M, Schierloh A, Zieglgansberger W . Infrared-guided laser stimulation of neurons in brain slices. Sci STKE. 2002; 2002(120):pl2. DOI: 10.1126/stke.2002.120.pl2. View

11.

Schmitz Y, Schmauss C, Sulzer D . Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J Neurosci. 2002; 22(18):8002-9. PMC: 6758092. View

12.

Hasue R, Shammah-Lagnado S . Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the rat. J Comp Neurol. 2002; 454(1):15-33. DOI: 10.1002/cne.10420. View

13.

Margolis E, Hjelmstad G, Bonci A, Fields H . Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci. 2003; 23(31):9981-6. PMC: 6740851. View

14.

Ungless M, Magill P, Bolam J . Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science. 2004; 303(5666):2040-2. DOI: 10.1126/science.1093360. View

15.

Beckstead M, Grandy D, Wickman K, Williams J . Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron. 2004; 42(6):939-46. DOI: 10.1016/j.neuron.2004.05.019. View

16.

Adell A, Artigas F . The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Neurosci Biobehav Rev. 2004; 28(4):415-31. DOI: 10.1016/j.neubiorev.2004.05.001. View

17.

Geffen L, Jessell T, Cuello A, Iversen L . Release of dopamine from dendrites in rat substantia nigra. Nature. 1976; 260(5548):258-60. DOI: 10.1038/260258a0. View

18.

Phillips A, Lepiane F . Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacol Biochem Behav. 1980; 12(6):965-8. DOI: 10.1016/0091-3057(80)90460-8. View

19.

Swanson L . The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull. 1982; 9(1-6):321-53. DOI: 10.1016/0361-9230(82)90145-9. View

20.

Albanese A, Minciacchi D . Organization of the ascending projections from the ventral tegmental area: a multiple fluorescent retrograde tracer study in the rat. J Comp Neurol. 1983; 216(4):406-20. DOI: 10.1002/cne.902160406. View